Bolland, Mark J <br/><br/>
Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 months.  [electronic resource] 

 -  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research  Aug 2008 
 - 1304-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-4681 
<br/><br/><label>Standard No.: </label>10.1359/jbmr.080312  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--administration & dosage<br/>Bone and Bones--drug effects<br/>Diphosphonates--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>HIV Infections--physiopathology<br/>Humans<br/>Imidazoles--administration & dosage<br/>Injections, Intravenous<br/>Male<br/>Middle Aged<br/>Placebos<br/>Time Factors<br/>Zoledronic Acid